Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4410

Previous 25           Next 25
Website Changes
03/10/2017 Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.
03/10/2017 4th ANNUAL HOOPS FOR HANNAH FUNDRAISER FOR BRAIN TUMOR RESEARCH
03/10/2017 Ependymoma Awareness Day.
03/10/2017 Clinical Trial Announcement Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Glioblastoma at First Recurrence or Progression
03/10/2017 Trump Chooses Dr. Scott Gottlieb To Head Food And Drug Administration
03/09/2017 Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization
03/08/2017 Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.
03/08/2017 Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children set to open soon
03/07/2017 Help us better Understand Patient Experiences with Glioblastoma Multiforme
02/26/2017 Renowned Neuro-oncologist Joining Northwestern
02/23/2017 Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Glioma
02/22/2017 UPDATED: Agenus’ lead cancer vaccine flops, investigators read last rites over glioblastoma PhII
02/21/2017 Help us better Understand Patient Experiences with Glioblastoma Multiforme
02/09/2017 VBI Vaccines Building On Duke University Research for New Cancer Therapy
02/09/2017 TRACON Pharmaceuticals Announces Top-line Results from NCI-Sponsored Phase 2 Trial of TRC105 in Recurrent Glioblastoma
02/09/2017 Trials Open for Enrollment: Phase II Study of VAL-083 in Patients with MGMT-unmethylated Bevacizumab-naïve Recurrent Glioblastoma Multiforme
02/07/2017 DelMar Pharmaceuticals Inc (DMPI) Moves Forward With Flagship Chemotherapy Into Phase II
02/06/2017 NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA
02/04/2017 17th Annual UCLA Brain Tumor Conference
02/04/2017 Optimism and Opportunity as we Initiate Clinical Trials for MGMT-unmethylated GBM Patients at MD Anderson
02/04/2017 Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
02/04/2017 FDA Grants New Clearance for Brain Surgery Technology
02/04/2017 Northwell Health is First on Long Island to Acquire Synaptive Medical’s BrightMatter™ Technology for Complex Brain Tumor and Spinal Surgery
02/04/2017 Researchers at Yale have taken steps toward a ‘completely unexpected’ new way to treat brain cancer
02/04/2017 New Brain Cancer Coalition Announces Precision Medicine Study During CHOP Event



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites